×

BMY battles lung cancer

5:15 PM ET Thu, 5 March 2015

Bristol-Myers hit a 14-year high after the company won expanded approval for its lung cancer drug more than 3-months ahead of schedule. Details, with CNBC's Meg Tirrell.